Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Haematologica
|
November 18, 2021
Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing
Axel Künstner, Hanno M Witte, Jörg Riedl, et al.
European Journal of Haematology
|
January 2, 2024
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients
Vanja Zeremski, Louisa Adolph, Sina Beer, et al.
The Oncologist
|
July 3, 2024
Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma
Annette Arndt, Christian Neumann, Armin Riecke, et al.
Journal of Hematology & Oncology
|
April 24, 2025
PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma
Vanja Zeremski, Tobias R Haage, Hanno M Witte, et al.
Blood Cancer Journal
|
May 27, 2021
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing
Niklas Gebauer, Axel Künstner, Julius Ketzer, et al.
Leukemia
|
April 10, 2024
Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features
Axel Künstner, Julian Schwarting, Hanno M Witte, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Haematologica
|
November 18, 2021
Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing
Axel Künstner, Hanno M Witte, Jörg Riedl, et al.
European Journal of Haematology
|
January 2, 2024
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients
Vanja Zeremski, Louisa Adolph, Sina Beer, et al.
The Oncologist
|
July 3, 2024
Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma
Annette Arndt, Christian Neumann, Armin Riecke, et al.
Journal of Hematology & Oncology
|
April 24, 2025
PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma
Vanja Zeremski, Tobias R Haage, Hanno M Witte, et al.
Blood Cancer Journal
|
May 27, 2021
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing
Niklas Gebauer, Axel Künstner, Julius Ketzer, et al.
Leukemia
|
April 10, 2024
Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features
Axel Künstner, Julian Schwarting, Hanno M Witte, et al.
Page
of 3